{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Ekso Bionics Holdings, Inc.
Is Ekso Bionics Holdings, Inc. technically bullish or bearish?
As of June 13, 2025, the technical trend has shifted to a strong bearish stance, supported by bearish MACD, Bollinger Bands, KST signals, moving averages, and underperformance relative to the S&P 500.
Who are in the management team of Ekso Bionics Holdings, Inc.?
As of March 2022, the management team of Ekso Bionics Holdings, Inc. includes Executive Chairman Steven Sherman, CEO Jack Peurach, and Directors Mary Cloyd, Rhonda Wallen, Theodore Wang, Marilyn Hamilton, and Charles Li. They oversee the company's strategic direction and operations.
What does Ekso Bionics Holdings, Inc. do?
Ekso Bionics Holdings, Inc. designs and sells wearable bionic exoskeletons in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $3 million and a net loss of $3 million, with a market cap of $9.36 million.
How big is Ekso Bionics Holdings, Inc.?
As of Jun 18, Ekso Bionics Holdings, Inc. has a market capitalization of 9.36 million, with net sales of 17.55 million and a net profit of -10.79 million over the last four quarters. Shareholder's funds are 12.71 million, and total assets amount to 26.65 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
